Evidence map›Paper›PMID 32014521›Full record

ArticleContraception2020

Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont.

Catalina N Rey, Gary J Badger, Heidi S Melbostad, Deborah Wachtel, Stacey C Sigmon, Lauren K MacAfee, Anne K Dougherty, Sarah H Heil

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contraception, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Catalina N ReyVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA; Department of Psychiatry, University of Vermont, Burlington, VT, USA.
Gary J BadgerVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA; Department of Medical Biostatistics, University of Vermont, Burlington, VT, USA.
Heidi S MelbostadVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA; Department of Psychological Science, University of Vermont, Burlington, VT, USA.
Deborah WachtelDepartment of Nursing, University of Vermont, Burlington, VT, USA.
Stacey C SigmonVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA; Department of Psychiatry, University of Vermont, Burlington, VT, USA; Department of Medical Biostatistics, University of Vermont, Burlington, VT, USA.
Lauren K MacAfeeDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of Vermont, Burlington, VT, USA.
Anne K DoughertyDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of Vermont, Burlington, VT, USA.
Sarah H HeilVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA; Department of Psychiatry, University of Vermont, Burlington, VT, USA; Department of Medical Biostatistics, University of Vermont, Burlington, VT, USA. Electronic address: sarah.heil@uvm.edu.
University of Vermont · USUniversity of Vermont Medical Center · US

Funding

Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SIGMON, STACEY C · 2013 to 2022
$21.3M
TRAINING IN BEHAV. PHARMACOLOGY OF HUMAN DRUG DEPENDENCET32DA007242 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HEIL, SARAH H, HIGGINS, STEPHEN T · 1990 to 2025
$8.2M
Medically-supervised withdrawal vs. agonist maintenance in the treatment of pregnant women with opioid use disorder: Maternal, fetal, and neonatal outcomesR01DA047867 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HEIL, SARAH H, JONES, HENDREE E · 2018 to 2022
$3.3M
Improving Effective Contraceptive use Among Opioid-Maintained Women: Stage IIR01DA036670 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HEIL, SARAH H · 2014 to 2019
$3.0M
NIDA NIH HHS R01 DA036670NIDA NIH HHS R01 DA047867NIDA NIH HHS T32 DA007242NIGMS NIH HHS P20 GM103644
6 · The paper itself

Abstract

objectivesTo evaluate perceptions of long-acting reversible contraceptives (LARC) among women receiving medication for opioid use disorder. STUDY

designCross-sectional survey of 200 women receiving medication for opioid use disorder in Vermont.

resultsA considerable proportion of women receiving medication for opioid use disorder in Vermont reported previous use of an IUD (40%) and/or a subdermal contraceptive implant (16%); the majority of prior LARC users were satisfied with their IUD (68%) or their implant (74%). Of the 38% of participants who had never considered IUD use, 85% percent (64/75) said that they knew nothing or only a little about IUDs. Of the 61% of participants who had never considered an implant, 81% percent (98/121) said that they knew nothing or only a little about the contraceptive method. The most commonly reported reasons for a lack of interest in the IUD and/or implant were concerns about side effects and preference for a woman-controlled method.

conclusionsGaps in LARC knowledge are common among those who have not used LARCs and concerns about side effects and preferences for a woman-controlled method limit some women's interest in these contraceptives. Additionally, reasons for dissatisfaction among past users are generally similar for IUD and implant and include irregular bleeding and having a bad experience with the method. IMPLICATIONS: Efforts to increase awareness of LARC methods among women receiving medication for opioid use disorder should address concerns about side effects and reproductive autonomy and encourage satisfied LARC users to share their experiences with their social networks.

Indexed as

Health Knowledge, Attitudes, PracticeOpiate Substitution TreatmentAdolescentAdultContraception BehaviorContraceptive Agents, FemaleContraceptive EffectivenessContraceptive Prevalence SurveysCross-Sectional StudiesDrug ImplantsFemaleHumansIntrauterine DevicesLong-Acting Reversible ContraceptionOpioid-Related DisordersPerceptionContraceptive Agents, FemaleDrug ImplantsImplantIntrauterine deviceLong-acting reversible contraceptionOpioid agonist treatmentOpioid use disorderUnintended pregnancy

Identifiers

PMID32014521
PMCPMC7510935
OpenAlexW3003375073

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.